The 3020insC mutation of the NOD2/CARD15 gene in patients with periodontal disease

European Journal of Oral Sciences

Volumn 112, Issue 4, 2004, Pages 316-319

  Folwaczny, Matthias ^a   Glas, Jürgen ^b   Török, Helga Paula ^b   Mauermann, Daniel ^a   Folwaczny, Christian ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Crohn's disease; NF B; NOD2 CARD15; Periodontitis; Polymorphisms

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FEMALE; GENE FREQUENCY; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PERIODONTITIS; POLYMERASE CHAIN REACTION; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; CARRIER PROTEINS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; GENE FREQUENCY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; NOD2 SIGNALING ADAPTOR PROTEIN; ODDS RATIO; PERIODONTITIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REGRESSION ANALYSIS;

EID: 4444383817     PISSN: 09098836     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0722.2004.00137.x     Document Type: Article

References (26)

1. HART TC, KORNMAN KS. Genetic factors in the pathogenesis of periodontitis. Periodontohgy 2000 1997; 14: 202-215.
2. PAGE RC, OFFENBACHER S, SCHROEDER HE, SEYMOUR GJ, KORNMAN KS. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodonlology 2000 1997; 14: 216-248.
3. SHAPIRA L, STABHOLZ A, RIECKMANN P, KRUSE N. Genetic polymorphism of the tumor necrosis factor (TNF)-alpha promotor region in families with localized early-onset periodontitis. J Periodont Res 2001; 36: 183-186.
4. INOHARA N, KOSEKI T, LIN J, DEL PESO L, LUCAS PC, CHEN FF, OGURA Y, NUNEZ G. An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J Biol Chem 2000; 275: 27823-27831.
5. ADEREM A, ULEVITCH RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000; 406: 785-787.
6. ALIPRANTIS AO, YANG RB, MARK MR, SUGETT S, DEVAUX B, RADOLF JD, KLIMPEL GR, GODOWSKI P, ZYCHLINSKY A. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 1999; 285: 736-739.
7. PHILPOTT DJ, YAMAOKA S, ISRAEL A, SANSONETTI PJ. Invasive Shigella flexneri activates NF-kappa B through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells. J Immunol 2000; 165: 903-914.
8. VAN HEEL DA, MCGOVERN DPB, JEWELL DP. Crohn's disease: genetic susceptibility, bacteria, and innate immunity. Lancet 2001; 357: 1902-1904.
9. INOHARA N, OGURA Y, CHEN FF, MUTO A, NUNEZ G. Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J Biol Chem 2001; 276: 2551-2554.
10. INOHARA N, KOSEKI T, DEL PESO L, HU Y, YEE C, CHEN S, CARRIO R, MERINO J, LIU D, Ni J, NUNEZ G. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor kappa B. J Biol Chem 1999; 274: 14560-14567.
11. OGURA Y, INOHARA N, BENITO A, CHEN FF, YAMAOKA S, NUNEZ G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappa B. J Biol Chem 2001; 276: 4812-4818.
12. HUGOT JP, CHAMAILLARD M, ZOUALI H, LESAGE S, CEZARD JP, BELAICHE J, ALMER S, TYSK C, O'MORAIN CA, GASSULL M, BINDER V, FINKEL Y, CORTOT A, MODIGLIANI R, LAURENT-PUIG P, GOWER-ROUSSEAU G, MACRY J, COLOMBEL JF, SAHBATOU M, THOMAS G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
13. OGURA Y, BONEN DK, INOHARA N, NICOLAE DL, CHEN FF, RAMOS R, BRITTON H, MORAN T, KARALIUSKAS R, DUERR RH, ACHKAR JP, BRANT SR, BAYLESS TM, KIRSCHNER BS, HANAUER SB, NUNEZ G, CHO JH. A frameshift mutation in Nod2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-606.
14. GIRARDIN SE, BONECA IG, VIALA J, CHAMAILLARD M, LABIGNE A, THOMAS G, PHILPOTT DJ, PHILIPPE J, SANSONETTI PJ. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003; 278: 8869-8872.
15. INOHARA N, OGURA Y, FONTALBA A, GUTIERREZ O, PONS F, CRESPO J, FUKASE K, INAMURA S, KUSUMOTO S, HASHIMOTO M, FOSTER SJ, MORAN AP, FERNANDEZ-LUNA JL, NUNEZ G. Host recognition of bacterial muramyl dipeptide mediated through NOD2. J Biol Chem 2003; 278: 5509-5512.
16. NYMAN S, LINDHE J. Examination of patients with periodontal disease. In: LINDHE J, KARRING T, LANG NP, eds. Clinical periodontology and implant dentistry. Copenhagen: Munksgaard, 1997; 383-395.
17. MILLER SA, DYKES DD, POLESKY HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
18. SOCRANSKY SS, HAFFAJEE A, CUGINI M, SMITH C, KENT RJ. Microbial complexes in subgingival plaque. J Clin Periodontol 1998; 25: 134-144.
19. ASSUMA R, OATES T, COCHRAN D, AMAR S, GRAVES D. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol 1998; 160: 403-409.
20. GRAVES D, JIANG Y, GENCO C. Periodontal disease: bacterial virulence factors, host response and impact on systemic health. Curr Opin Infect Dis 2000; 13: 227-232.
21. MCGOVERN DP, VAN HEEL DA, AHMAD T, JEWELL DP. NOD2 (CARD15), the first susceptibility gene for Crohn's disease. Gut 2001; 49: 752-754.
22. GAMONAL J, BASCONES A, ACEVEDO A, BLANCO E, SILVA A. Apoptosis in chronic adult periodontitis analyzed by in situ DNA breaks, electron microscopy, and immunohistochemistry. J Periodontol 2001; 72: 517-525.
23. RADLMAYR M, TÖRÖK HP, MARTIN K, FOLWACZNY C. The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. Gastroenterology 2002; 122: 2091-2092.
24. MICELI-RICHARD C, ZOUALI H, LESAGE S, THOMAS G, HUGOT JP, SAID-NAHAL R, BREBAN M. CARD15/NOD2 analyses in spondylarthropathy. Arthritis Rheum 2002; 46: 1405-1406.
25. FLEMMIG TF. Periodontitis. Ann Periodontol 1999; 4: 32-37.
26. TONETTI MS, MOMBELLI A. Early-onset periodontitis. Ann Periodontol 1999; 4: 39-52.